Both in Pharmaceuticals
iBio vs InMed Pharmaceuticals
Over the past year IBIO returned −47.7% and INM returned +405.8%; their daily moves had a correlation of 0.03.
IBIO −47.7% INM +405.8%Growth of $1, one year, split-adjusted
| Metric | IBIO | INM |
|---|---|---|
| Price | $0.8000 | $8.75 |
| Market cap | $51.4M | $48.1M |
| Today | −2.85% | +420.83% |
| 1 month | −23.8% | +557.9% |
| 6 months | −54.8% | +1104.6% |
| Year to date | −58.5% | +725.5% |
| 1 year | −54.5% | +373.0% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 514.5× | 24.8× |
| Net cash | $88.0M | $2.2M |
| Dividend yield | — | — |
| Volatility (60d) | 65.6% | 338.3% |
| Short % of float | 6.8% | 0.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).